1-5 of 5
Nagendra K. Chaturvedi
Close
Sort by
Journal Articles

CLL Cells within the Proliferation Centers of the Patient Lymph Nodes Are Enriched for Notch Signaling, Thus NOTCH a Viable Target for CLL Therapy

Shantaram S. Joshi, Matt Kilng, Furqan Mehdi, Mamta Shukla, Ashima Bhakri, Vipul Shukla, Nagendra K. Chaturvedi, Hamid Band, Javeed Iqbal
Journal: Blood
Blood (2023) 142 (Supplement 1): 6519.
https://doi.org/10.1182/blood-2023-190855
Published: 2023
Journal Articles

Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL

Ashima Shukla, Karan Rai, Vipul Shukla, Nagendra K. Chaturvedi, R. Gregory Bociek, Samuel J. Pirruccello, Hamid Band, Runqing Lu, Shantaram S. Joshi
Journal: Blood
Blood (2016) 127 (19): 2310–2321.
https://doi.org/10.1182/blood-2015-09-669317
Published: 2016
Includes: Supplemental data
Journal Articles

The Role Of PRDM1 and Its Interacting Proteins In The Pathogenesis Of Chronic Lymphocytic Leukemia

Ashima Shukla, BS, Nagendra K Chaturvedi, PhD, Shantaram S Joshi, PhD, Philip Bierman, MD, Adam Cornish, Sanjit Pandey, M.S., Chittibabu Guda, Ph.D
Journal: Blood
Blood (2013) 122 (21): 2865.
https://doi.org/10.1182/blood.V122.21.2865.2865
Published: 2013
Journal Articles

Stromal Tumor Microenvironment in CLL: Regulation of Leukemic Progression

Nagendra K Chaturvedi, PhD, Adam K Ahrens, BA, Ashima Shukla, BS, Christine E Gilling, BS, Amit K. Mittal, PhD, DVM, MS, Philip Bierman, MD, Dennis D Weisenburger, MD, Runqing Lu, PhD, Shantaram S Joshi, PhD
Journal: Blood
Blood (2012) 120 (21): 1781.
https://doi.org/10.1182/blood.V120.21.1781.1781
Published: 2012
Journal Articles

Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Targeting NF-κB and mTOR Signaling Pathways in Vitro and in Vivo

Nagendra K Chaturvedi, PhD, Rajkumar Rajule, PhD, Shukla Ashima, BS, Prakash Radhakrishnan, PhD, Amarnath Natarajan, PhD, Julie M Vose, MD, MBA, Shantaram S Joshi, PhD
Journal: Blood
Blood (2012) 120 (21): 63.
https://doi.org/10.1182/blood.V120.21.63.63
Published: 2012